Literature DB >> 1950632

Psychometric evaluation of a standardized and expanded Brief Psychiatric Rating Scale.

A Hafkenscheid1.   

Abstract

The interrater reliability, factorial and discriminant validity of a standardized and expanded Brief Psychiatric Rating Scale (BPRS-E) were investigated in a heterogeneous short-stay group of psychiatric inpatients in the Netherlands (n = 162). Repeated separate interviews by single clinicians (psychiatrists, residents or clinical psychologists), best reflecting the way the BPRS is usually employed in clinical practice and psychopharmacological research, were used to determine interrater reliability (n = 79). Although the 5 subscales of the original 18-item BPRS (BPRS-18) were successfully cross-validated in this Dutch sample, 4 of these subscales (except for thought disturbance) were found to lack interrater reliability. The 10-item schizophrenia scale derived from the BPRS-18 by a Scandinavian group met the standard of acceptable interrater reliability; BPRS-18 and BPRS-E global scales approximated this standard. For the thought disturbance subscale, the schizophrenia scale and for BPRS-18 and BPRS-E global scales, findings supported discriminatory power.

Entities:  

Mesh:

Year:  1991        PMID: 1950632     DOI: 10.1111/j.1600-0447.1991.tb03147.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  15 in total

1.  Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E).

Authors:  P M Dingemans; D H Linszen; M E Lenior; R M Smeets
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

2.  Italian validation of MOAS and NOSIE: a useful package for psychiatric assessment and monitoring of aggressive behaviours.

Authors:  Francesco Margari; Rosanna Matarazzo; Massimo Casacchia; Rita Roncone; Massimiliano Dieci; Simona Safran; Giovanni Fiori; Lucia Simoni
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

3.  Cognitive Functioning in Euthymic Bipolar Patients on Monotherapy with Novel Antipsychotics or Mood Stabilizers.

Authors:  Vesile Şentürk Cankorur; Hilal Demirel; Cem Atbaşoğlu
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

Review 4.  A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.

Authors:  M Zaudig
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

5.  Symptom dimensions as predictors of clinical outcome, duration of hospitalization, and aggressive behaviours in acutely hospitalized patients with psychotic exacerbation.

Authors:  Alessandro Colasanti; Silvia Paletta; Donatella Moliterno; Alessandra Mazzocchi; Massimo Carlo Mauri; Alfredo Carlo Altamura
Journal:  Clin Pract Epidemiol Ment Health       Date:  2010-08-09

6.  Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia.

Authors:  Dongyoon Shin; Sang Jin Rhee; Daun Shin; Eun-Jeong Joo; Hee Yeon Jung; Sungwon Roh; Sang-Hyuk Lee; Hyeyoung Kim; Minji Bang; Kyu Young Lee; Se Hyun Kim; Jihyeon Lee; Yoseop Kim; Injoon Yeo; Yeongshin Kim; Jaenyeon Kim; Jun Soo Kwon; Kyooseob Ha; Yong Min Ahn; Youngsoo Kim
Journal:  Clin Transl Med       Date:  2022-06

7.  Inter-rater reliability of the Brief Psychiatric Rating Scale and the Groningen Social Disabilities Schedule in a European multi-site randomized controlled trial on the effectiveness of acute psychiatric day hospitals.

Authors:  Matthias Schützwohl; Joanna Jarosz-Nowak; Jane Briscoe; Krzysztof Szajowski; Thomas Kallert
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

8.  The relationship of insight to psychopathology in schizophrenia: a cross-sectional study.

Authors:  V M Aga; A K Agarwal; S C Gupta
Journal:  Indian J Psychiatry       Date:  1995-07       Impact factor: 1.759

9.  Amygdala connectivity differs among chronic, early course, and individuals at risk for developing schizophrenia.

Authors:  Alan Anticevic; Yanqing Tang; Youngsun T Cho; Grega Repovs; Michael W Cole; Aleksandar Savic; Fei Wang; John H Krystal; Ke Xu
Journal:  Schizophr Bull       Date:  2013-12-22       Impact factor: 9.306

10.  Psychosis assessment in early-stage Parkinson's disease: comparing Parkinson's psychosis questionnaire with the brief psychiatric rating scale in a portuguese sample.

Authors:  I Cargaleiro; M Serra; J Alves da Silva; B Neto; M Gonçalves-Pereira; P Bugalho
Journal:  Parkinsons Dis       Date:  2012-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.